Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Viatris Inc. (VTRS) Q2 2023 Earnings Call Transcript
12:13pm, Monday, 07'th Aug 2023
Viatris Inc. (NASDAQ:VTRS ) Q2 2023 Earnings Call Transcript August 7, 2023 8:30 AM ET Company Participants William Szablewski - Head of Global Capital Markets Scott Smith - Chief Executive Officer Ra
Viatris (VTRS) Q2 Earnings and Revenues Beat Estimates
09:53am, Monday, 07'th Aug 2023
Viatris (VTRS) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.88 per share a year ago.
Viatris beats second-quarter revenue estimates, says divestiture plans on track
08:29am, Monday, 07'th Aug 2023
Viatris Inc beat Wall Street estimates for second-quarter revenue on Monday, on the strength of its branded drug portfolio, sending its shares up 2% in premarket trading.
Want $1,500 in Annual Passive Income? Invest This Much in Viatris Stock Each Month for 5 Years
08:20am, Friday, 04'th Aug 2023
Viatris is an appealing stock for dividend investors. Its business model should be sufficient to deliver long-term growth.
Deerfield Management Company, L.P.
10:03pm, Tuesday, 01'st Aug 2023
Deerfield Management Company, L.P. (Series C), a renowned investment firm, recently made a significant addition to its portfolio.
Viatris (VTRS) to Report Q2 Earnings: What's in the Offing?
01:23pm, Monday, 31'st Jul 2023
Viatris' (VTRS) Q2 results are likely to be impacted by foreign exchange rates. Nevertheless, momentum in the branded business is likely to have continued.
Dividend Stock Watch List: Lanny's August 2023 Edition
01:40am, Saturday, 29'th Jul 2023
Dividend Stock Watch List: Lanny's August 2023 Edition
You can still run with the stock market's bulls, but watch the exits
03:57pm, Thursday, 27'th Jul 2023
The stock market, as measured by the S&P 500 Index SPX, -0.64% ), has been moving upward. The U.S. benchmark index is essentially crawling up the higher “modified Bollinger Bands” (mBB), which is
Viatris Stock: Bull vs. Bear
06:00am, Saturday, 22'nd Jul 2023
Investors like Viatris for its dividend and low valuation. Still, Viatris sales right now are on the decline.
1 Reason I Wouldn't Buy This High-Yielding Dividend Stock
09:20am, Thursday, 20'th Jul 2023
Viatris offers investors a high dividend yield of 4.7%. The company's underlying business, however, has struggled to generate growth.
Better Pharma Buy: Viatris vs. Pfizer
02:00pm, Wednesday, 19'th Jul 2023
Viatris has filled its pipeline with promising products -- that could add billions to revenue. Pfizer aims to launch a record number of drugs over the coming year or so.
Viatris: Developing Into A Fantastic Investment Opportunity
12:28am, Tuesday, 18'th Jul 2023
Viatris Inc. has a low valuation with a forward P/E of under 4 and a market cap of over $12 billion, predicted to reach $15.75 billion in revenues by 2023. The company recently acquired Oyster Point P
Better High-Yield Dividend Stock: Altria or Viatris?
05:00pm, Saturday, 15'th Jul 2023
Tobacco giant Altria and generic drug specialist Viatris sport enormous dividend yields right now. In this head-to-head comparison, Viatris stands out as the better overall buy.
3 Reasons to Buy Viatris Stock, and 1 Reason to Sell
07:45am, Friday, 14'th Jul 2023
Viatris is making good progress on its strategic plan to cut its debt. It's also going to have more money to give back to investors relatively soon.
3 Healthcare Stocks With Healthy Dividends
09:05am, Thursday, 13'th Jul 2023
The stocks' shares have all declined to begin the year. Each company had a sluggish first quarter, but has a pipeline with plenty of potential.
